Age-related macular degeneration

Also called AMD

There are 1,342 papers on age-related macular degeneration in aging research: 25 trials and 677 observational studies in people, 116 in animals, 28 in cells, 410 reviews. The newest story, Nov 12, 2026: “Blood protein patterns linked to later macular degeneration”.

Disease

1,342 papers study it669 more mention it1,071 findings

42 new papers in 30 daysSee all 2,011 papers on age-related macular degeneration

At a glance

Age-related macular degeneration is associated with frailty and accelerated ocular aging in human studies. Human cohorts link malnutrition, metabolic vulnerability and clonal hematopoiesis of indeterminate potential with higher disease risk. A human trial reports no clear effect of omega-3 fatty acids or aspirin on age-related macular degeneration.

1,071 findings in 635 papers from 1996 to 2026, 114 of them since April 2026

“indicated a 23% decreased risk in the cocoa extract group during the first 2 years of treatment (HR, 0.77; 95% CI, 0.59-1.01)”
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical TrialJAMA ophthalmology2025doi:10.1001/jamaophthalmol.2025.0353
  • Human trial25
  • Humans677
  • Animals116
  • Cells28
  • In silico74

Interventions

56

Mediterranean diet

downin humans2no changein humans2downin reviews1OR 0.88–0.96

5 studies
  1. Mediterranean diet was not clearly linked with age-related macular degeneration in humans (adjusted OR 0.88, 95% CI 0.61-1.29).

    “no significant association was observed between the aMED score and AMD in women (adjusted OR = 0.88; 95% CI = 0.61-1.29; p-trend = 0.691).”

    Humansfemalesn = 1,191

    Associations of mediterranean diet score and age-related macular degeneration in Korean elderly

    BMC public health

  2. Mediterranean diet protects against age-related macular degeneration in humans.

    “nutrients, such as polyphenols, like resveratrol, carotenoids, especially lutein and zeaxanthin, omega-3 polyunsaturated fatty acids, or the Mediterranean and Oriental dietary patterns, may have a protective effect against AMD”

    Review

    Diet and Age-Related Macular Degeneration: A view on the relationship between dietary patterns, dietary elements supplementation, and Age-Related Macular Degeneration

    Medical Science

  3. Mediterranean diet protects against age-related macular degeneration (non-advanced AMD).

    “Mediterranean dietary patterns appear protective.”

    Reviewnon-advanced AMD

    Non-advanced age-related macular degeneration: Current concepts and future perspectives

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)

  4. Mediterranean diet showed no clear effect on age-related macular degeneration in humans (cross-sectional studies) (OR = 0.96 (95% CI: 0.83-1.11)).

    “meta-analysis of cross-sectional studies (pooled OR = 0.96; 95% CI: 0.83-1.11; p = 0.6243; I2 = 0%) found no significant association between MD adherence and AMD.”

    Reviewcross-sectional studies

    Mediterranean Diet on Development and Progression of Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Observational Studies

    Nutrients

  5. Mediterranean diet decreases age-related macular degeneration in humans.

    “Adhering to the Mediterranean diet, which encompasses these elements, can be recommended as a dietary pattern for AMD.”

    Review

    A narrative review on dietary components and patterns and age-related macular degeneration

    Nutrition research reviews

More on Mediterranean diet

Aspirin

no changein humans4RR 0.88–1.02

4 studies
  1. Aspirin showed no clear effect on age-related macular degeneration in humans (rate ratio 0.88; 95% CI 0.69 to 1.12).

    “There was no significant effect of randomisation to aspirin compared with placebo on AMD diagnoses, which were reported by 122 (1.6%) participants assigned aspirin, compared with 138 (1.8%) assigned placebo (rate ratio 0.88; 95% CI 0.69 to 1.12; p=0.31; ).”

    Human trial7.4 yearsn = 15,480

    Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes

    BMJ open

  2. Aspirin showed no clear effect on age-related macular degeneration in humans (diabetes but no evident cardiovascular disease) (1.6% vs 1.8%, RR 0.88 (95% CI 0.69-1.12)).

    “rate ratio 0.88; 95% CI 0.69 to 1.12; p=0.31”

    Human trialdiabetes but no evident cardiovascular disease100 mg daily7.4 yearsn = 15,480

    Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes

    BMJ open

  3. Aspirin showed no clear effect on age-related macular degeneration in humans (RR 1.02, 95% CI 0.85-1.22).

    “Cumulative AMD incidence was 195 of 1004 (19.4%) in the aspirin group and 187 of 979 (19.1%) in the placebo group (relative risk [RR], 1.02; 95% CI, 0.85-1.22; P = .86).”

    Human trialenteric coated100 mg daily3.1 years

    Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical Trial

    JAMA ophthalmology

  4. Aspirin was not clearly linked with age-related macular degeneration in humans after adjusting for LDL-C and APOA1.

    “after adjusting for LDL-C and APOA1, the direct effect of aspirin on AMD was attenuated to non-significance”

    Humansafter adjusting for LDL-C and APOA1

    Causal relationship between aspirin use and age-related macular degeneration

    Eye (London, England)

  5. Aspirin showed no clear effect on age-related macular degeneration in humans.

    “two large randomized controlled trials showed no benefit for AMD”

    Review

    Systemic medications and their impact on age-related macular degeneration development and progression: a review of current evidence

    Current opinion in ophthalmology

More on Aspirin

Metformin

no changein humans3downin humans1RR 0.9

4 studies
  1. Metformin showed no clear effect on age-related macular degeneration in humans (population at high risk for developing diabetes) (30.2% vs 30.7%).

    “There was no significant difference in the presence of AMD between the 3 groups: 152 (29.6%) in the lifestyle arm, 165 (30.2%) in the metformin arm, and 162 (30.7%) in the placebo arm.”

    Human trialpopulation at high risk for developing diabetesretinamean [SD], 8.5 [9.3] yearsn = 1,592

    Association of Metformin With the Development of Age-Related Macular Degeneration

    JAMA ophthalmology

  2. Metformin was not clearly linked with age-related macular degeneration in humans (without AMD at baseline, propensity score matched) (RR 0.90, 95% CI 0.86-0.94).

    “After propensity score matching, participants prescribed metformin had comparable risk of developing any AMD relative to those not prescribed metformin (RR, 0.90; 95% CI, 0.86-0.94).”

    Humanswithout AMD at baseline, propensity score matched

    Metformin and the Development of Age-Related Macular Degeneration

    JAMA ophthalmology

  3. Metformin is linked with less age-related macular degeneration in diabetic patients.

    “Metformin, insulin, and sulfonylureas demonstrated independent protective effects against AMD development.”

    Humansin diabetic patients

    INTERACTIONS OF METFORMIN AND OTHER MEDICATIONS IN REDUCING THE ODDS OF AGE-RELATED MACULAR DEGENERATION IN A COHORT OF PATIENTS WITH DIABETES

    Retina (Philadelphia, Pa.)

  4. Metformin showed no clear effect on age-related macular degeneration in humans.

    “The pooled analysis showed no statistically significant difference between the metformin group and the non-metformin group regarding age-related macular degeneration”

    Review

    The role of oral metformin in preventing and treating age-related macular degeneration: A meta-analysis

    Medicine

More on Metformin

Smoking cessation

downin humans2−10% decrease

2 studies
  1. Smoking cessation is linked with lower age-related macular degeneration in humans (10.0% decrease).

    “a reduction of smoking exposure to its theoretical minimum risk exposure level (TMREL) would lead to an estimated 10.0% decrease in AMD DALYs in 2021”

    Humans

    Potential to improve the burden of age-related macular degeneration: results from the Global Burden of Disease Study 2021

    Eye (London, England)

  2. Smoking cessation protects against age-related macular degeneration in humans.

    “Lifestyle factors including smoking cessation, weight management, and regular physical activity also confer protective benefits.”

    Review

    The Macular Degeneration Preventive Diet and Lifestyle for Providers and Patients: From Evidence to Action

    American journal of lifestyle medicine

More on Smoking cessation

Lutein

downin humans2

2 studies
  1. Lutein protects against age-related macular degeneration in humans.

    “There is evidence of a protective effect for individual nutrients such as lutein, zeaxanthin, zinc and omega‐3 fatty acids.”

    Reviewretina

    Nutrition and dietary supplements in age-related macular degeneration

    Die Ophthalmologie

  2. Lutein prevents age-related macular degeneration in humans.

    “Many epidemiological and clinical studies indicate the effective use of lutein to help prevent AMD.”

    Review

    Lutein: A natural defence combating age-related macular degeneration

    Phytomedicine : international journal of phytotherapy and phytopharmacology

More on Lutein

Omega-3 fatty acids

no changein humans1RR 0.99

1 study
  1. Omega-3 fatty acids showed no clear effect on age-related macular degeneration in humans (rate ratio 0.99; 95% CI 0.78 to 1.27).

    “Similarly, there was no significant effect of randomisation to omega-3 FAs compared with placebo.”

    Human trial7.4 yearsn = 15,480

    Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes

    BMJ open

  2. Omega-3 fatty acids showed no clear effect on age-related macular degeneration in humans (diabetes but no evident cardiovascular disease) (1.7% vs 1.7%, RR 0.99 (95% CI 0.78-1.27)).

    “rate ratio 0.99; 95% CI 0.78 to 1.27; p=0.99”

    Human trialdiabetes but no evident cardiovascular disease1 g daily7.4 yearsn = 15,480

    Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes

    BMJ open

More on Omega-3 fatty acids

Educational level

no changein humans1

1 study
  1. Educational level was not clearly linked with age-related macular degeneration in humans (multivariable analysis).

    “educational level was not significantly associated with myopic macular degeneration (MMD; P = 0.72), age-related macular degeneration (AMD; P = 0.21)”

    Humansmultivariable analysiseyen = 13,094

    Education showed no clear link to five major eye disorders

    Scientific reports

More on Educational level

Calcifediol

no changein humans1HR 1.01

1 study
  1. Calcifediol was not clearly linked with age-related macular degeneration in humans (weighted CGPS allele score) (HR 1.01, 95% CI 1.00-1.02).

    “Genetically, each increase in the 25-hydroxyvitamin D-increasing weighted CGPS allele score was associated with a hazard ratio of 1.01 (95% confidence interval: 1.00-1.02) in CGPS”

    Humansweighted CGPS allele score

    Genetic study does not support vitamin D lowering eye disease risk

    Acta ophthalmologica

More on Calcifediol

Physical activity

no changein humans1

1 study
  1. Physical activity was not clearly linked with age-related macular degeneration in humans.

    “No significant longitudinal associations were found between PA and AMD, POAG, or senile cataract.”

    Humans

    More activity linked to fewer new diabetic eye disease diagnoses

    Journal of sport and health science

More on Physical activity

Histamine H2-receptor antagonists

no changein humans1

1 study
  1. Histamine H2-receptor antagonists were not clearly linked with age-related macular degeneration in humans (sHR 1.02, 95% CI 0.88 to 1.19).

    “No association was observed between H2-antagonists and AMD (sHR=1.02, 95% CI 0.88 to 1.19; p=0.784”

    Humans

    Long-term proton-pump inhibitor use linked to eye disease

    BMJ open ophthalmology

More on Histamine H2-receptor antagonists

Theobroma cacao flavanols

no changein humans1HR 0.87

1 study
  1. Theobroma cacao flavanols showed no clear effect on age-related macular degeneration in humans (composite of incident AMD and progression to advanced AMD, cocoa extract vs placebo) (HR 0.87 (95% CI 0.71-1.08)).

    “cocoa extract supplementation for a median period of 3.6 years among older women and men had no effect overall on occurrence of AMD”

    Human trialcomposite of incident AMD and progression to advanced AMD, cocoa extract vs placebococoa extract, 500 mg/day cocoa flavanols500 mg/day cocoa flavanolsmedian 3.6 yearsn = 21,442

    Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial

    JAMA ophthalmology

More on Theobroma cacao flavanols

Lifestyle modification

no changein humans1

1 study
  1. Lifestyle modification showed no clear effect on age-related macular degeneration in humans (population at high risk for developing diabetes) (29.6% vs 30.7%).

    “There was no significant difference in the presence of AMD between the 3 groups: 152 (29.6%) in the lifestyle arm, 165 (30.2%) in the metformin arm, and 162 (30.7%) in the placebo arm.”

    Human trialpopulation at high risk for developing diabetesretinan = 1,592

    Association of Metformin With the Development of Age-Related Macular Degeneration

    JAMA ophthalmology

More on Lifestyle modification

All 56

Effects

35

Rod-mediated dark adaptation

downin humans1

1 study
  1. Age-related macular degeneration is linked with worse rod-mediated dark adaptation in humans (early and intermediate AMD) (Minimum Clinically Important Difference at 3 years follow-up).

    “Of seven vision tests utilised in ALSTAR2, only RMDA achieved a Minimum Clinically Important Difference at 3 years follow-up.”

    Humansearly and intermediate AMD3 years

    Impaired Rod-Mediated Vision is the Functional Hallmark of Ageing and Early and Intermediate Age-Related Macular Degeneration

    Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)

More on Rod-mediated dark adaptation

Bipolar cell dendritic branching

upin reviews1

1 study
  1. Age-related macular degeneration increases bipolar cell dendritic branching (compared with normally aging retina).

    “rapid growth and remodeling of dendritic branching of bipolar cells, and the formation of multiple tangential contacts”

    Reviewcompared with normally aging retinaretina

    Features of retina remodeling during its physiological aging and age-related macular degeneration

    Russian Ophthalmological Journal

Allantoin

upin humans1

1 study
  1. Age-related macular degeneration is linked with higher allantoin in AMD patients.

    “elevated levels of serum allantoin, a product of oxidative damage to urate in humans”

    Humansin AMD patients

    Are low ergothioneine levels a risk factor for age-related macular degeneration and other ocular disorders?

    medRxivPreprint

More on Allantoin

Ergothioneine

downin humans1

1 study
  1. Age-related macular degeneration is linked with lower ergothioneine in humans (Compared with ocularly-normal age-matched individuals).

    “Compared with ocularly-normal age-matched individuals, AMD patients exhibited significantly lower serum ET”

    HumansCompared with ocularly-normal age-matched individuals

    Are low ergothioneine levels a risk factor for age-related macular degeneration and other ocular disorders?

    medRxivPreprint

More on Ergothioneine

Osteoporosis

no changein silico1

1 study
  1. Age-related macular degeneration showed no clear effect on osteoporosis in silico (genetically predicted).

    “while no significant causal effects were observed for wet, early, or late AMD. Reverse MR analysis did not indicate any causal effect of AMD on OP.”

    In silicogenetically predicted

    Exploring the causal relationship between osteoporosis and age-related macular degeneration: Evidence from observational studies and mendelian randomization

    Experimental gerontology

More on Osteoporosis

Activities of daily living impairment

upin humans1

1 study
  1. Age-related macular degeneration is linked with higher activities of daily living impairment in humans (compared to controls) (92.2% vs 55.6%, p < 0.001).

    “More participants with age-related macular degeneration (92.2%) had impairment with one or more activities of daily living as compared to controls (55.6%,p < 0.001).”

    Humanscompared to controls

    Patients with age-related macular degeneration face impairment in activities of daily living

    Clinical & experimental optometry

Total normalized retinal pigment epithelium reflectivity

downin humans1

1 study
  1. Age-related macular degeneration is linked with lower total normalized retinal pigment epithelium reflectivity in humans (intermediate AMD vs eAMD and healthy eyes) (P < 0.01).

    “TNRR was lower in iAMD eyes compared to eAMD and healthy eyes (P < 0.01)”

    Humansintermediate AMD vs eAMD and healthy eyesretinan = 502

    Total Retinal Pigment Epithelium Thickness and Reflectivity, in Relation to Histology and Vision, at the Aging-AMD Transition: ALSTAR2 Baseline

    Investigative ophthalmology & visual science

More on Total normalized retinal pigment epithelium reflectivity

Total retinal pigment epithelium thickness

downin humans1

1 study
  1. Age-related macular degeneration is linked with lower total retinal pigment epithelium thickness in humans (intermediate AMD vs eAMD and healthy eyes) (P < 0.001).

    “TRPET was significantly thinner in iAMD compared with eAMD and healthy eyes (P < 0.001)”

    Humansintermediate AMD vs eAMD and healthy eyesretinan = 502

    Total Retinal Pigment Epithelium Thickness and Reflectivity, in Relation to Histology and Vision, at the Aging-AMD Transition: ALSTAR2 Baseline

    Investigative ophthalmology & visual science

More on Total retinal pigment epithelium thickness

Alzheimer's disease

no changein humans1

1 study
  1. Age-related macular degeneration was not clearly linked with Alzheimer's disease in humans (global network).

    “No significant association between AMD and AD was observed in the global network.”

    Humansglobal network

    Longitudinal Assessment of Age-Related Macular Degeneration and Risk of Dementia Using Clinical Setting Data

    Ophthalmology science

More on Alzheimer's disease

Physical function

downin humans1

1 study
  1. Age-related macular degeneration is linked with worse physical function in elderly in geriatric homes.

    “AMD patients had a higher risk of falls and more impairment in ADL and IADL.”

    Humansin elderly in geriatric homes

    Epidemiology of age-related macular degeneration among elderly in geriatric homes, East Cairo, Egypt

    BMC public health

All 35

Upstream

26

Inflammation

mediatesin humans3

3 studies
  1. Inflammation is linked with age-related macular degeneration in humans (Exploratory mediation analysis of the eGDR-AMD association) (0.3%–6.6% of the eGDR-AMD association).

    “Systemic inflammatory markers (C-reactive protein, neutrophils, neutrophil-lymphocyte ratio, systemic immune-inflammatory index) mediated only a small proportion (0.3%–6.6%) of the eGDR-AMD association.”

    HumansExploratory mediation analysis of the eGDR-AMD associationMedian follow-up of 13.4 yearsn = 429,844

    Association of Estimated Glucose Disposal Rate and Risk of Age-Related Macular Degeneration: Evidence from the UK Biobank

    Current eye research

  2. Inflammation is linked with age-related macular degeneration in humans (37.5%).

    “Specific inflammatory and erythrocyte-related biomarkers partially (37.5%) mediated the incidence of age-related macular degeneration as substantial biological mechanisms following handgrip strength decrease.”

    Humans13 yearsn = 382,174

    Association between low handgrip strength and the increased risk of age-related macular degeneration: results from UK biobank cohort study

    Aging clinical and experimental research

  3. Inflammation is linked with age-related macular degeneration in humans (between low lung function and AMD).

    “Inflammatory markers and erythrocyte-related measures mediated this relationship, acting as a pathway through which low lung function influenced AMD.”

    Humansbetween low lung function and AMD

    Association between low lung function and the increased risk of age-related macular degeneration: A population-based prospective cohort study

    Journal of global health

More on Inflammation

Thyroid peroxidase antibody positivity

no changein humans1OR 0.93

1 study
  1. Thyroid peroxidase antibody positivity was not clearly linked with age-related macular degeneration in humans (Mutually adjusted observational model) (OR 0.93, 95% CI 0.63–1.37).

    “TPOAb positivity was not associated with AMD (OR, 0.93; 95% CI, 0.63-1.37; P = 0.676).”

    HumansMutually adjusted observational modeln = 2,967

    Association of Thyroid Autoimmunity With Age-Related Macular Degeneration in U.S. Adults

    Translational vision science & technology

More on Thyroid peroxidase antibody positivity

Severe systemic lupus erythematosus

no changein humans1

1 study
  1. Severe systemic lupus erythematosus was not clearly linked with age-related macular degeneration in humans (Treatment-defined SLE severity; adjusted analysis).

    “Severe SLE was not associated with higher AMD hazards after adjustment.”

    HumansTreatment-defined SLE severity; adjusted analysis

    Systemic lupus erythematosus is associated with age-related macular degeneration risk in a nationwide Korean cohort

    Scientific reports

More on Severe systemic lupus erythematosus

4-pyridoxic acid

no changein humans1

1 study
  1. 4-pyridoxic acid was not clearly linked with age-related macular degeneration in humans (P > .05).

    “No significant association was found between 4-PA levels and the odds of AMD (P > .05).”

    Humans

    Association between vitamin B6 metabolism and the prevalence of age-related macular degeneration: A cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES)

    Medicine

More on 4-pyridoxic acid

Oxidative phosphorylation

upin reviews1

1 study
  1. Oxidative phosphorylation induces age-related macular degeneration.

    “In the high-energy environment of the retinal pigment epithelium, mitochondrial dysfunction dominates and drives AMD.”

    Reviewretinal pigment epithelium

    The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics

    Investigative ophthalmology & visual science

More on Oxidative phosphorylation

Glycerophosphoethanolamine

downin silico1

1 study
  1. Glycerophosphoethanolamine protects against age-related macular degeneration in silico across AMD subtypes.

    “notably, among lipid classes, glycerophosphoethanolamine (gpe) metabolites consistently exhibited protective effects.”

    In silicoacross AMD subtypes

    Genetic Evidence for Causal Effects of Blood Metabolites on Age-Related Macular Degeneration and its Subtypes

    Translational vision science & technology

More on Glycerophosphoethanolamine

Celiac disease

no changein humans1RR 1.09

1 study
  1. Celiac disease was not clearly linked with age-related macular degeneration in humans (RR = 1.09, CI = 0.88-1.35).

    “Celiac disease was not associated with increased AMD risk (n = 9315, RR = 1.09, CI = 0.88-1.35).”

    Humansn = 9,315

    Malabsorption Syndromes and Risk of Age-Related Macular Degeneration

    Ophthalmology. Retina

More on Celiac disease

Chronic kidney disease severity

no changein humans1RR 1.08

1 study
  1. Chronic kidney disease severity showed no clear effect on age-related macular degeneration in humans (between moderate and advanced CKD stages) (RR: 1.08; 95% CI: 0.48-2.46).

    “there was no significant difference in AMD prevalence between moderate and advanced CKD stages (RR: 1.08; 95% CI: 0.48-2.46).”

    Reviewbetween moderate and advanced CKD stages

    Chronic kidney disease increases the risks of age-related macular degeneration: a systematic review and meta-analysis

    Frontiers in medicine

HOEM thickness

no changein humans1

1 study
  1. HOEM thickness was not clearly linked with age-related macular degeneration in humans (multivariable analysis adjusted for age, axial length, EZ, POS, choroid, RPE/BM) (beta: 0.03; p=0.08).

    “thickness of Henle's fibre layer, outer nuclear layer, external limiting membrane and myoid zone (HOEM) combined was not significantly associated with AMD prevalence (beta: 0.03; p=0.08)”

    Humansmultivariable analysis adjusted for age, axial length, EZ, POS, choroid, RPE/BMretina

    Photoreceptor layer thickness in age-related macular degeneration: the Beijing Eye Study

    The British journal of ophthalmology

More on HOEM thickness

Telomere length

no changein humans1HR 1.042

1 study
  1. Telomere length was not clearly linked with age-related macular degeneration in humans after adjusting for multiple confounders (HR=1.042, 95% CI: 0.992 to 1.094).

    “Shorter LTL was not associated with incident AMD risk (HR=1.042, 95% CI: 0.992 to 1.094; p=0.10) after adjusting for multiple confounders.”

    Humansafter adjusting for multiple confoundersn = 332,123

    Association of leucocyte telomere length with incident age-related macular degeneration: a prospective UK Biobank Study

    The British journal of ophthalmology

More on Telomere length

All 26

Associations

448

Smoking

upin humans20downin humans3HR 1.284

23 studies
  1. Smoking is linked with a higher risk of age-related macular degeneration in patients with dry AMD versus never-smokers (HR 1.284).

    “Combustible smokers with dry AMD progressed to wet AMD faster than never-smokers (HR 1.284).”

    Humansin patients with dry AMD versus never-smokers

    Retinal disease risk in electronic cigarette users versus combustible cigarette smokers: a retrospective cohort study

    AJO International

  2. Smoking is associated with age-related macular degeneration in humans (r = -0.25, p < 0.001).

    “and a significant negative correlation with smoking prevalence (r = -0.25, p < 0.001).”

    Humans

    Global association between ambient air pollution and age-related macular degeneration: an ecological analysis across 203 countries

    Environmental science and pollution research international

  3. Smoking is associated with age-related macular degeneration in humans.

    “Statistically Significant associations were observed between ARMD and risk factors such as diabetes, hypertension, ischaemic heart disease, high body mass index and smoking.”

    Humansn = 500

    Prevalence of age-related macular degeneration and its association with systemic risk factors

    Global Journal of Cataract Surgery and Research in Ophthalmology

  4. Smoking is linked with a higher risk of age-related macular degeneration in humans (propensity score matched) (RR 1.85).

    “Increased risks were also consistent across glaucoma subtypes (RR 1.57-2.47), AMD (RR 1.85), and diabetic retinopathy (RR 1.21).”

    Humanspropensity score matchedeye10-year

    Smoking and Risk of Vision Threatening Complications: A Global Database Analysis

    Clinical ophthalmology (Auckland, N.Z.)

  5. Smoking is associated with age-related macular degeneration in humans.

    “Approximately one in six elderly individuals in this cohort had AMD, with smoking and inadequate sunlight exposure as significant risk factors.”

    Humansn = 150

    A cross-sectional study on the prevalence and risk factors of age-related macular degeneration

    Global Journal of Cataract Surgery and Research in Ophthalmology

  6. Smoking is associated with age-related macular degeneration in humans (58,858 YLDs (+47.1% from 1990)).

    “In 2021, the global burden of smoking-associated AMD reached 58858 YLDs (a 47.1% increase from 1990)”

    Humans1990 to 2021

    Global burden of smoking-associated age-related macular degeneration: Spatiotemporal trends from 1990 to 2021 and projections to 2040

    Tobacco induced diseases

  7. Smoking is associated with age-related macular degeneration in patients with AMD.

    “proportion of DALYs attributable to smoking in patients with AMD decreased globally and across all SDI regions from 1990 to 2021”

    Humansin patients with AMD1990 to 2021

    Trends in the global disease burden of age-related macular degeneration from 1990 to 2021

    European journal of ophthalmology

  8. Smoking is linked with a higher risk of age-related macular degeneration in humans.

    “Decomposition analysis indicated that population growth and aging are the primary driving factors for the increase in AMD DALYs”

    Humans

    Potential to improve the burden of age-related macular degeneration: results from the Global Burden of Disease Study 2021

    Eye (London, England)

  9. Smoking is associated with age-related macular degeneration in humans (globally).

    “Smoking-related AMD burden decreased globally”

    Humansglobally

    The global burden and attributable risk factor analysis of age-related macular degeneration in 204 countries and territories, 1990-2021

    Eye (London, England)

  10. Smoking is linked with a higher risk of age-related macular degeneration in humans.

    “In men, BMI and cigarette smoking were also positively associated with AMD changes.”

    Humansmalesn = 1,418

    Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (Study of Health in Pomerania-TREND-1)

    Medical science monitor : international medical journal of experimental and clinical research

All 23

More on Smoking

Metformin

downin humans14upin humans1OR 0.63–1.39

14 studies
  1. Metformin is linked with a lower risk of age-related macular degeneration in humans (type 2 diabetes) (OR 0.63, 95% CI 0.43 to 0.92, p=0.02).

    “Metformin was associated with reduced incidence of intermediate AMD by 5 years after adjusting for confounders (complete record OR 0.63, 95% CI 0.43 to 0.92, p=0.02).”

    Humanstype 2 diabetes5 years

    Metformin and incidence of age-related macular degeneration in people with diabetes: a population-based 5-year case-control study

    BMJ open ophthalmology

  2. Metformin is linked with a lower risk of age-related macular degeneration in humans (patients with diabetes) (HR 0.68, 95% CI 0.54–0.85).

    “Incident AMD was documented in 122 (3.3%) patients who had been exposed to metformin and 184 (4.9%) who had not (HR, 0.68; 95% CI, 0.54-0.85).”

    Humanspatients with diabetes≥5 consecutive yearsn = 7,496

    Long-Term Metformin Use and Reduced Risk of Age-Related Macular Degeneration: A Large Database Study

    Ophthalmology. Retina

  3. Metformin is linked with a lower risk of age-related macular degeneration in humans (patients without diabetes) (AOR 0.83, 95% CI 0.74-0.87).

    “exposure to any metformin was associated with reduced odds of any AMD development (adjusted odds ratio [AOR], 0.83; 95% CI, 0.74-0.87)”

    Humanspatients without diabetes2 years

    Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes

    JAMA ophthalmology

  4. Metformin is linked with a higher risk of age-related macular degeneration in patients with type 2 diabetes mellitus (OR: 1.39, 95% CI: 1.08-1.78).

    “Patients treated with >25 DDD/month of metformin had a higher risk of AMD (OR: 1.39; 95% CI: 1.08-1.78).”

    Humansin patients with type 2 diabetes mellitus>25 DDD/month5 years

    Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study

    Frontiers in pharmacology

  5. Metformin is linked with a lower risk of age-related macular degeneration in patients with type 2 diabetes mellitus (OR: 0.93, 95% CI: 0.88-0.99).

    “patients with T2DM treated with <5 defined daily dose (DDD)/month of metformin had a lower risk of AMD (odds ratios [OR]: 0.93; 95% confidence interval [CI]: 0.88 0.99).”

    Humansin patients with type 2 diabetes mellitus<5 DDD/month5 years

    Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study

    Frontiers in pharmacology

  6. Metformin is linked with a lower risk of age-related macular degeneration in humans (OR = 0.97; 95% confidence interval [CI], 0.95-0.99).

    “any metformin use was associated with decreased odds of developing dry AMD (OR = 0.97; 95% confidence interval [CI], 0.95-0.99).”

    Humans

    Association of Metformin and Other Diabetes Medication Use and the Development of New-Onset Dry Age-Related Macular Degeneration: A Case-Control Study

    Investigative ophthalmology & visual science

  7. Metformin is linked with a lower risk of age-related macular degeneration in humans (type 2 diabetes mellitus) (HR 0.756, 95% CI 0.673-0.850).

    “The hazard ratio (HR) and 95% confidence interval (CI) for ever versus never users was 0.756 (0.673-0.850).”

    Humanstype 2 diabetes mellitus

    The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin

    Pharmaceuticals (Basel, Switzerland)

  8. Metformin lowers the risk of age-related macular degeneration in both diabetic and non-diabetic cohorts.

    “suggest a modest reduction in AMD risk associated with metformin use in both diabetic and non-diabetic cohorts”

    Reviewin both diabetic and non-diabetic cohorts

    Emerging strategies in drug repurposing for decreasing the risk of age-related macular degeneration

    Expert opinion on drug discovery

  9. Metformin lowers the risk of age-related macular degeneration in observational studies.

    “metformin use was associated with a lower risk of AMD development, particularly dry AMD”

    Reviewin observational studies

    Effects of Metformin on Mitochondrial Health and Oxidative Stress in Age-Related Macular Degeneration: A Systematic Review

    Cureus

  10. Metformin lowers the risk of age-related macular degeneration in humans.

    “several meta-analyses and large cohort study showing reduced AMD odds”

    Review

    Systemic medications and their impact on age-related macular degeneration development and progression: a review of current evidence

    Current opinion in ophthalmology

All 15

More on Metformin

Mediterranean diet

downin humans9OR 0.58

9 studies
  1. Mediterranean diet is linked with a lower risk of age-related macular degeneration in humans after adjusting for confounding factors (adjusted OR 0.58, 95% CI 0.39-0.88).

    “Multiple logistic regression analysis revealed a significantly negative association between the aMED score and AMD (adjusted ORs = 0.58; 95% confidence interval = 0.39-0.88; p-trend = 0.021) in older men”

    Humansafter adjusting for confounding factorsmalesn = 895

    Associations of mediterranean diet score and age-related macular degeneration in Korean elderly

    BMC public health

  2. Mediterranean diet is linked with a lower risk of age-related macular degeneration in humans (high adherence vs low adherence to Mediterranean diet) (reduced by 60%).

    “The AMD risk was reduced by 60% in subjects with high adherence to the Mediterranean diet compared to subjects with low adherence to the Mediterranean diet.”

    Humanshigh adherence vs low adherence to Mediterranean diet

    Interaction between genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration. Coimbra Eye Study Report 8

    Eye and vision (London, England)

  3. Mediterranean diet lowers the risk of age-related macular degeneration in humans.

    “greater adherence to Mediterranean dietary patterns is associated with a lower risk of AMD progression”

    Review

    MEDITERRANEAN DIET AND AGE-RELATED MACULAR DEGENERATION: EVIDENCE FOR A PLANT-FORWARD NUTRITIONAL STRATEGY IN PREVENTION AND DISEASE PROGRESSION

    International Journal of Innovative Technologies in Social Science

  4. Mediterranean diet lowers the risk of age-related macular degeneration in humans (20-56%).

    “dietary patterns rich in lutein, zeaxanthin, and omega-3 fatty acids-particularly through green leafy vegetables, fatty fish, and Mediterranean diet adherence-reduce AMD progression risk by 20-56%”

    Review

    The Macular Degeneration Preventive Diet and Lifestyle for Providers and Patients: From Evidence to Action

    American journal of lifestyle medicine

  5. Mediterranean diet lowers the risk of age-related macular degeneration in humans.

    “In addition, a Mediterranean diet correlates with a reduced risk of AMD.”

    Reviewretina

    Nutrition and dietary supplements in age-related macular degeneration

    Die Ophthalmologie

  6. Mediterranean diet lowers the risk of age-related macular degeneration in humans.

    “smoking cessation, adherence to a Mediterranean diet, and regular physical activity are associated with a reduced risk of AMD over time”

    Review

    Risk factors for age-related macular degeneration : Lessons learned from current data

    Die Ophthalmologie

  7. Mediterranean diet lowers the risk of age-related macular degeneration in humans.

    “adherence to a Mediterranean diet, rich in vegetables, fruits, legumes, whole grains, and nuts, has been linked to a lower risk of both early and late AMD”

    Review

    Modifiable Lifestyle Risk Factors and Strategies for Slowing the Progression of Age-Related Macular Degeneration

    Vision (Basel, Switzerland)

  8. Mediterranean diet lowers the risk of age-related macular degeneration in humans (HR 0.82; 95% CI: 0.75-0.90).

    “Subjects with medium-high (hazard ratio [HR] 0.82; 95% confidence interval [CI]: 0.75-0.90) adherence to the MD showed a reduced risk of developing AMD.”

    Review

    Mediterranean diet as a modifiable risk factor for age-related macular degeneration: A systematic review and meta-analysis

    Tzu chi medical journal

  9. Mediterranean diet lowers the risk of age-related macular degeneration in humans.

    “higher MD adherence was associated with reduced risks of incident DR, incident AMD and progression to late AMD”

    Review

    The Mediterranean Diet and Age-Related Eye Diseases: A Systematic Review

    Nutrients

More on Mediterranean diet

Age

upin humans8OR 1.082–1.14

8 studies
  1. Age is linked with a higher risk of age-related macular degeneration in humans (population-based cohort) (OR per year 1.08, 95% CI 1.05-1.11, p<0.001).

    “Multivariate analysis showed that ARMD prevalence increased significantly with age (OR per year 1.08; 95% CI 1.05-1.11, p<0.001)”

    Humanspopulation-based cohortn = 1,794

    Markedly Lower Rates of Age-Related Macular Degeneration in Malta Compared to European Countries: Results from The Malta Eye Study, Indicating Possible Divergent Genetic Ancestry?

    Clinical ophthalmology (Auckland, N.Z.)

  2. Age is linked with a higher risk of age-related macular degeneration in humans (OR: 1.12, 95% CI: 1.04, 1.19, P = 0.001).

    “Higher prevalence of any AMD and late AMD was significantly correlated with urban region of habitation (OR:3.34; 95% CI:2.37,4.71; P < 0.001), and with older age (OR:1.12; 95% CI:1.04,1.19; P = 0.001)”

    Humansretinan = 932

    Prevalence of age-related macular degeneration and retinal pseudodrusen in an elderly population. The ural very old study

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

  3. age is linked with a higher risk of age-related macular degeneration in humans.

    “The risk of AMD changes increased with age”

    Humansn = 1,418

    Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (Study of Health in Pomerania-TREND-1)

    Medical science monitor : international medical journal of experimental and clinical research

  4. Age is associated with age-related macular degeneration in humans (participants aged 50 to over 80).

    “The prevalence of the bilateral involvement of late AMD increased with age.”

    Humansparticipants aged 50 to over 80

    Bilateral Involvement of Age-Related Macular Degeneration in South Korea: Findings from the Korea National Health and Nutrition Examination Survey 2017-2020

    Ophthalmic epidemiology

  5. Age is associated with age-related macular degeneration in humans (non-irradiated individuals applying for work involving ionizing radiation).

    “the prevalence of age-related macular degeneration in non-irradiated individuals determined in the pilot group was high and statistically significantly increased with age.”

    Humansnon-irradiated individuals applying for work involving ionizing radiationretinan = 1,064

    PREVALENCE OF AGE-MACULAR DEGENERATION IN PERSONS OF WORKING AGE WHO APPLIED TO PARTICIPATE IN WORK IN ACTION CONDITIONS IONIZING RADIATION: PRELIMINARY RESULTS

    Problemy radiatsiinoi medytsyny ta radiobiolohii

  6. Age is associated with age-related macular degeneration in humans (OR 1.082, 95% CI 1.067-1.096, P < 0.001).

    “Pilots with age-related macular degeneration features were positively associated with age (OR: 1.082, CI: 1.067-1.096, P < 0.001)”

    Humansn = 2,781

    PREVALENCE AND RISK FACTORS OF AGE-RELATED MACULAR DEGENERATION FEATURES AMONG PILOTS

    Retina (Philadelphia, Pa.)

  7. Age raises the risk of age-related macular degeneration in humans (OR 1.14, 95% CI 1.09-1.19, p < 0.001).

    “per 5-year increment in age (OR: 1.14; 95% CI: 1.09-1.19; p < 0.001)”

    Reviewper 5-year incrementn = 38,697

    Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies

    Frontiers in medicine

  8. Age is associated with age-related macular degeneration in humans (2% in 40-49 vs 32.3% in ≥ 80).

    “The prevalence of AMD was 2% in 40-49, and 32.3% in the ≥ 80 population.”

    Revieweyen = 16,120

    Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis

    BMC ophthalmology

Fine particulate matter

upin humans7HR 1.04

7 studies
  1. Fine particulate matter is linked with a higher risk of age-related macular degeneration in humans.

    “Higher levels of Lden, Lnight, and PM2.5 were consistently associated with increased AMD risk”

    Humans

    Traffic noise, air pollution, and greenness in relation to age-related macular degeneration: Evidence from a cross-national cohort study

    Environmental pollution (Barking, Essex : 1987)

  2. Fine particulate matter is linked with a higher risk of age-related macular degeneration in humans (HR 1.04 (95% CI 1.02-1.07) per SD).

    “1.04(1.02, 1.07), 1.02(1.00, 1.04), and 1.04(1.02, 1.06), respectively.”

    Humans13.83 yearsn = 445,237

    Air pollutants, genetic susceptibility, and the risk of age-related macular degeneration: a large prospective cohort study

    European journal of epidemiology

  3. Fine particulate matter is associated with age-related macular degeneration in humans (national level).

    “with a correlation between national ASDRs and PM2.5 levels”

    Humansnational level

    The global burden and attributable risk factor analysis of age-related macular degeneration in 204 countries and territories, 1990-2021

    Eye (London, England)

  4. Fine particulate matter is associated with age-related macular degeneration in humans (National age-standardized prevalence rates worldwide in 2019) (Prevalence r = 0.67; DALY rate r = 0.54).

    “National prevalence rates of VI and three major ocular diseases correlate significantly with PM2.5 exposure levels, worldwide.”

    HumansNational age-standardized prevalence rates worldwide in 2019

    The Correlation of Global Burden of Vision Impairment and Ambient Atmospheric Fine Particulate Matter

    Journal of current ophthalmology

  5. Fine particulate matter is linked with a higher risk of age-related macular degeneration in humans (pooled OR 1.16 (95% CI: 1.11-1.21)).

    “Four studies evaluated the association between particulate matter less than 2.5 μm in diameter (PM2.5) and AMD”

    Humans

    Association between ambient air pollution and age-related macular degeneration: a meta-analysis

    BMC ophthalmology

  6. Fine particulate matter is linked with a higher risk of age-related macular degeneration in humans (highest vs lowest quartile) (OR 2.602 (95% CI 1.516, 4.468)).

    “A significant positive association was detected between AMD and PM2.5 level”

    Humanshighest vs lowest quartile

    Joint effects of meteorological factors and PM2.5 on age-related macular degeneration: a national cross-sectional study in China

    Environmental health and preventive medicine

  7. Fine particulate matter is associated with age-related macular degeneration in humans.

    “fine particulate matter (PM2.5) and nitrogen dioxide (NO2) have the most consistent epidemiological evidence for adverse effects on retinal health, particularly in relation to age-related macular degeneration (AMD).”

    Reviewretina

    Environmental Pollution and Related Redox Pathways Contributing to Retinal Diseases

    Antioxidants (Basel, Switzerland)

More on Fine particulate matter

Ozone

upin humans6OR 1.06–5.42

6 studies
  1. Ozone is associated with age-related macular degeneration in humans (Korean adults; fully adjusted analysis) (3-year OR 1.12, 95% CI 1.04–1.22 per IQR increase).

    “O3 exposure was significantly associated with higher odds of AMD across all exposure windows”

    HumansKorean adults; fully adjusted analysisper interquartile range increase in O3 concentration3-year moving averagen = 13,985

    Long-term ambient ozone exposure and prevalence of age-related macular degeneration in Korean adults: a nationwide cross-sectional study with stratified analyses

    BMC public health

  2. Ozone is linked with a higher risk of age-related macular degeneration in humans (OR 5.42, p < 0.001).

    “Multivariable regression analyses identified PM2.5 (odds ratio [OR] 8.09, p < 0.001) and ozone (OR 5.42, p < 0.001) as independent predictors of AMD prevalence.”

    Humans

    Global association between ambient air pollution and age-related macular degeneration: an ecological analysis across 203 countries

    Environmental science and pollution research international

  3. Ozone is linked with a higher risk of age-related macular degeneration in humans (high exposure vs. low exposure) (+101% risk (p for trend < 0.001)).

    “risk of AMD increased by 28% for the medium- and 101% for the high-exposure groups relative to the low-exposure group (p for trend < 0.001)”

    Humanshigh exposure vs. low exposuren = 27,923

    Ozone exposure and increased risk of age-related macular degeneration: Evidence from nationwide cohort and toxicological studies

    Innovation (Cambridge (Mass.))

  4. Ozone is linked with a higher risk of age-related macular degeneration in humans (HR 1.20 (95% CI 1.11–1.29)).

    “and 1.20 (1.11, 1.29) in two-exposure models, respectively.”

    Humansn = 19,707

    Association of exposure to ultraviolet radiation and warm-season ozone air pollution with incident age-related macular degeneration: A nationwide cohort study in China

    The Science of the total environment

  5. Ozone is linked with a higher risk of age-related macular degeneration in humans (pooled OR 1.06 (95% CI: 1.05-1.07)).

    “and 1.06 (95% CI: 1.05-1.07), respectively.”

    Humans

    Association between ambient air pollution and age-related macular degeneration: a meta-analysis

    BMC ophthalmology

  6. Ozone is linked with a higher risk of age-related macular degeneration in humans (warm-season ozone concentration below 110 μg/m3).

    “Every 10 μg/m3 increment in warm-season ozone concentration, the adjusted odds ratio (OR) for AMD were 1.15 (1.13, 1.16) and 1.66 (1.63, 1.69) when the warm-season ozone concentration was below or above 110 μg/m3, respectively.”

    Humanswarm-season ozone concentration below 110 μg/m3every 10 μg/m3 increment

    Association of long-term ozone air pollution and age-related macular degeneration in older Chinese population

    The Science of the total environment

More on Ozone

Male sex

upin humans5downin humans1OR 0.84–2

6 studies
  1. Male sex is associated with age-related macular degeneration in humans (adjusted models) (OR = 2.00, 95% CI 1.02-4.00).

    “In adjusted models, male sex (OR = 2.00, 95% CI 1.02-4.00) and lower income were strongly associated with referable AMD prevalence”

    Humansadjusted modelsretinan = 312

    Elevated prevalence of age-related macular degeneration in a low-income urban primary care setting

    Discover public health

  2. Male sex is linked with a higher risk of age-related macular degeneration in humans (patients with diabetes) (AOR 2.04, 95% CI 1.17 to 3.56).

    “Male sex (adjusted OR (AOR) 2.04, 95% CI 1.17 to 3.56)”

    Humanspatients with diabetesn = 832

    Burden and predictors of age-related macular degeneration among old age patients with diabetes attending comprehensive specialised hospitals in Northwest Ethiopia: a multicentre cross-sectional prospective study

    BMJ open

  3. Male sex is linked with a higher risk of age-related macular degeneration in humans (population-based cohort) (OR 1.57, 95% CI 1.01-2.44, p=0.043).

    “and in the male sex (OR 1.57; 95% CI 1.01-2.44, p=0.043).”

    Humanspopulation-based cohortn = 1,794

    Markedly Lower Rates of Age-Related Macular Degeneration in Malta Compared to European Countries: Results from The Malta Eye Study, Indicating Possible Divergent Genetic Ancestry?

    Clinical ophthalmology (Auckland, N.Z.)

  4. Male sex is linked with a higher risk of age-related macular degeneration in humans (health screening examination).

    “The male sex was strongly associated with an increased risk of both early/intermediate and advanced AMD (p < 0.001 for both).”

    Humanshealth screening examinationretinamalesn = 73,574

    A Comprehensive Health Screening Program Reveals the Prevalence of and Risk Factors for Age-Related Macular Degeneration: A Cross-Sectional Analysis

    Biomedicines

  5. Male sex is associated with age-related macular degeneration in humans (multivariate analysis) (OR 1.27, 95% CI 1.05-1.53).

    “male sex (p = 0.014; OR, 1.27; 95% CI, 1.05-1.53)”

    Humansmultivariate analysis

    Prevalence and Risk Factors of Age-Related Macular Degeneration in South Korea: Korea National Health and Nutrition Examination Survey

    Ophthalmic epidemiology

  6. Male sex lowers the risk of age-related macular degeneration in humans (OR 0.84, 95% CI 0.72-0.98, p = 0.027).

    “We noted male versus female was associated with a reduced risk of AMD (OR: 0.84; 95% CI: 0.72-0.98; p = 0.027).”

    Reviewn = 38,697

    Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies

    Frontiers in medicine

Statins

downin humans5upin humans1−48% risk reductionHR 0.74

6 studies
  1. Statins are linked with a lower risk of age-related macular degeneration in humans (patients with type 2 diabetes and dyslipidemia) (HR 0.74 (95% CI: 0.57-094)).

    “High-intensity statin use was associated with a reduced risk of combined AMD at 3 and 5 years (HR: 0.74 (95% CI: 0.57-094) and 0.79 (95% CI: 0.62-0.98), respectively).”

    Humanspatients with type 2 diabetes and dyslipidemia3 years

    Potency Matters: The Role of Statin Intensity in Modulating Risk for Age-Related Macular Degeneration

    American journal of ophthalmology

  2. Statins are linked with a lower risk of age-related macular degeneration in humans (AHR = 0.79, 95% CI: 0.69-0.91).

    “statin use for over 2 years was associated with a significantly lower risk of AMD compared to nonstatin users (AHR = 0.79, 95% CI: 0.69-0.91)”

    Humans>2 years

    Impact of long-term statin therapy on age-related macular degeneration: A nationwide population-based study

    British journal of clinical pharmacology

  3. Statins are linked with a higher risk of age-related macular degeneration in humans (multivariable logistic regression) (P < 0.001).

    “statin use and low and high HDL were significantly associated with increased AMD risk (P < 0.001 for all variables)”

    Humansmultivariable logistic regression

    High-Density Lipoproteins Associated with Age-Related Macular Degeneration in the All of Us Research Program

    Ophthalmology

  4. Statins are linked with a lower risk of age-related macular degeneration in humans (adjusted for age, sex, body mass index, smoking, diabetes, and GRS) (48% risk reduction).

    “Statin intake reduced the risk for progression to AMD in 48%”

    Humansadjusted for age, sex, body mass index, smoking, diabetes, and GRS

    Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study-Report 9

    Investigative ophthalmology & visual science

  5. Statins lower the risk of age-related macular degeneration in humans (treatment duration exceeding 2 years and medium-intensity to high-intensity dosing).

    “treatment duration exceeding 2 years and medium-intensity to high-intensity dosing may confer protection against AMD development”

    Reviewtreatment duration exceeding 2 years and medium-intensity to high-intensity dosingmedium-intensity to high-intensityexceeding 2 years

    Systemic medications and their impact on age-related macular degeneration development and progression: a review of current evidence

    Current opinion in ophthalmology

  6. Statins lower the risk of age-related macular degeneration in humans.

    “associations between several candidates and decreased risk of AMD development or progression. Such candidates include the more extensively studied metformin and statins”

    Review

    Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining

    Experimental biology and medicine (Maywood, N.J.)

More on Statins

Physical activity

downin humans4no changein humans1RR 0.92

5 studies
  1. Physical activity is associated with age-related macular degeneration in humans (Chinese population; individual component score).

    “Among the individual component scores, significant inverse associations were observed for physical activity and smoking status.”

    HumansChinese population; individual component score

    Associations of Life’s Essential 8 with age-related macular degeneration

    The British journal of ophthalmology

  2. Physical activity is linked with a lower risk of age-related macular degeneration in humans (HR 0.85, 95% CI 0.75-0.97).

    “and age-related macular degeneration (AMD, HR = 0.85, 95% CI: 0.75-0.97, P = 0.016).”

    Humans

    Accelerometer-derived "weekend warrior" physical activity pattern and risk of age-related eye diseases: a prospective cohort study

    Eye and vision (London, England)

  3. Physical activity is linked with a lower risk of age-related macular degeneration in humans (OR 0.77 (95% CI: 0.66-0.89)).

    “Engaging in moderate-to-vigorous physical activity significantly reduced the risk of AMD with an odds ratio of 0.77 (95% CI: 0.66-0.89).”

    Humans

    Genetically determined physical activity levels, sedentary behaviours, and their association with the risk of age-related macular degeneration

    The Journal of international medical research

  4. Physical activity is associated with age-related macular degeneration in humans (high vs. low) (RR 0.92, 95% CI 0.84–1.01).

    “and for age-related macular degeneration was 0.92 (95% CI: 0.84–1.01, I2 = 60%, n = 14)”

    Reviewhigh vs. low

    Physical activity and the risk of cataract and age-related macular degeneration: a systematic review and meta-analysis of cohort studies

    BMC ophthalmology

  5. Physical activity lowers the risk of age-related macular degeneration in humans.

    “smoking cessation, adherence to a Mediterranean diet, and regular physical activity are associated with a reduced risk of AMD over time”

    Review

    Risk factors for age-related macular degeneration : Lessons learned from current data

    Die Ophthalmologie

More on Physical activity

Hypertension

upin humans5OR 1.24–5.8

5 studies
  1. Hypertension is associated with age-related macular degeneration in humans.

    “Statistically Significant associations were observed between ARMD and risk factors such as diabetes, hypertension, ischaemic heart disease, high body mass index and smoking.”

    Humansn = 500

    Prevalence of age-related macular degeneration and its association with systemic risk factors

    Global Journal of Cataract Surgery and Research in Ophthalmology

  2. Hypertension is linked with a higher risk of age-related macular degeneration in humans (patients with diabetes) (AOR 2.45, 95% CI 1.56 to 3.85).

    “presence of hypertension (AOR 2.45, 95% CI 1.56 to 3.85)”

    Humanspatients with diabetesn = 832

    Burden and predictors of age-related macular degeneration among old age patients with diabetes attending comprehensive specialised hospitals in Northwest Ethiopia: a multicentre cross-sectional prospective study

    BMJ open

  3. Hypertension is associated with age-related macular degeneration in All of Us validation dataset (OR 5.80, 95% CI 4.25–7.93, P < .05).

    “essential hypertension (OR: 5.80, 95% CI: [4.25-7.93], P < .05)”

    Humansin All of Us validation dataset

    Predicting Early Onset of Age-Related Macular Degeneration: A Machine Learning Approach

    American journal of ophthalmology

  4. Hypertension raises the risk of age-related macular degeneration in humans (meta-analysis of observational studies) (OR 1.24 (95% CI = 1.09-1.4, P = .0007)).

    “hypertension, cardiovascular diseases, and diabetes were statistically significant predictors for AMD occurrence, with ORs of 1.11 (95% CI = 1.06-1.15, P < .00001), 1.63 (95% CI = 1.13-2.35, P = .009), 1.86 (95% CI = 1.33-2.6, P = .0003), 1.24 (95% CI = 1.09-1.4, P = .0007)”

    Reviewmeta-analysis of observational studies

    Risk factors for age-related macular degeneration: Updated systematic review and meta-analysis

    Medicine

  5. Hypertension raises the risk of age-related macular degeneration in Iran (OR 1.512, 95% CI 1.119-2.044).

    “hypertension (HTN) (OR: 1.512; 95% CI: 1.119-2.044)”

    Reviewin Iran

    Age-Related Macular Degeneration Prevalence and its Risk Factors in Iran: A Systematic Review and Meta-Analysis Study

    Journal of current ophthalmology

More on Hypertension

Medios-ai

upin humans1

1 study
  1. Medios-ai predicts age-related macular degeneration in humans (AMD screening) (AUROC 0.93, sensitivity 88.9%, specificity 97.5%).

    “For AMD (n = 56), sensitivity was 88.9% (95% CI: 77-96), specificity 97.5% (95% CI: 95-99), AUROC 0.93.”

    Human trialAMD screeningn = 56

    Smartphone-based offline AI for multi-disease retinal screening: Real-world accuracy

    European journal of ophthalmology

More on Medios-ai

Theobroma cacao flavanols

downin humans1HR 0.77

1 study
  1. Theobroma cacao flavanols lower the risk of age-related macular degeneration in humans (first 2 years of treatment, separate Cox models for nonproportional hazards) (23% decreased risk; HR 0.77 (95% CI 0.59-1.01)).

    “indicated a 23% decreased risk in the cocoa extract group during the first 2 years of treatment (HR, 0.77; 95% CI, 0.59-1.01)”

    Human trialfirst 2 years of treatment, separate Cox models for nonproportional hazardscocoa extract, 500 mg/day cocoa flavanols500 mg/dayfirst 2 years

    Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial

    JAMA ophthalmology

More on Theobroma cacao flavanols

All 448

Trial sponsors

Funding

137 grants since 2016

National Eye Institute$99MBrightFocus Foundation$5.7MJapan Society for the Promotion of Science¥162M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human cohorts link frailty, frailty progression and accelerated ocular aging with higher age-related macular degeneration risk. Healthy plant-based and Mediterranean diets are associated with lower risk, whereas a human trial shows no clear effect of omega-3 fatty acids or aspirin on the disease.

  2. Summary rewritten as its findings changed.

    As it read before

    Age-related macular degeneration is associated with frailty and accelerated biological and ocular aging in human studies, and with higher mortality in a cohort at high cardiovascular risk. Observational studies link metformin use in people with type 2 diabetes to lower risk, while a human trial shows no clear effect of omega-3 fatty acids or aspirin.

  3. Summary rewritten as its findings changed.

    As it read before

    Human studies associate age-related macular degeneration with frailty, accelerated biological and ocular aging, and impaired vision and daily activities. Cohorts link malnutrition and cardiometabolic disease to higher AMD risk, while studies in people with type 2 diabetes associate metformin use with lower risk; a cohort of people at high cardiovascular risk links AMD to higher mortality.

  4. Summary rewritten as its findings changed.

    As it read before

    Frailty, malnutrition and higher metabolic vulnerability are associated with higher age-related macular degeneration risk in human cohorts. Human studies also link the disease to accelerated ocular aging. A human trial reports lower risk with antioxidant and zinc tablets over 6.3 years.

  5. Summary rewritten as its findings changed.

    As it read before

    In human cohorts, higher oxidative balance scores lower the risk of age-related macular degeneration, whereas CETP inhibitors, vitamin D insufficiency and vitamin D deficiency increase disease risk.

Latest

Dec 2025: 34Jan 2026: 47Feb 2026: 33Mar 2026: 51Apr 2026: 43May 2026: 40Jun 2026: 43Jul 2026: 39Aug 2026: 31Sep 2026: 32Oct 2026: 26Nov 2026: 18437 papers in 12 months
Frontiers in Aging

Serotonin receptor loss may leave retinal cells prone to stress

Experiments in retinal pigment epithelium cells linked reduced receptor activity to defects resembling those seen in age-related macular degeneration.Experiments in retinal pigment epithelium cells linked reduced receptor activity to defects resembling those seen in age-related macular degeneration.

Accepted, not yet published: human cell studyEye
Journal of Translational Medicine

Blood protein patterns linked to later macular degeneration

Blood protein patterns in 45,379 people varied with time to diagnosis, with one protein group’s average pattern changing approximately nine years before diagnosis.Blood protein patterns in 45,379 people varied with time to diagnosis, with one protein group’s average pattern changing approximately nine years before diagnosis.

Cohort · 45,379 peopleAge-related macular degeneration
Medicine

Gut microbes and blood metabolites linked to macular degeneration

A genetic analysis in European populations linked 22 groups of gut microbes and 59 blood metabolites to age-related macular degeneration risk.A genetic analysis in European populations linked 22 groups of gut microbes and 59 blood metabolites to age-related macular degeneration risk.

Mendelian randomizationEye

See all 2,011 papers on age-related macular degeneration